Hiroshi Harada

Dr. Hiroshi Harada


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
THToru Hachisuga
Toru Hachisuga
YHYoshikazu Harada
Yoshikazu Harada
MSMami Shibahara
Mami Shibahara
MMMidori Murakami
Midori Murakami
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background: The immunoreactive (IR) subtype is one of the subtypes of high-grade serous ovarian carcinoma (HGSOC) with intra-tumoral lymphocytic infiltration. A positive prognostic correlation between IR subtype and R0 + optimal surgery has been reported. This study investigates the prognostic significance of tumor-infiltrating lymphocytes (TILs) in the suboptimal surgery group of HGSOCs. Methods: After reviewing 318 malignant ovarian tumors detected in our database between 2000 and 2017, 74 HGSOCs with supplemental p53 immunostaining were selected. Differences in progression-free survival (PFS) and overall survival (OS) between the two groups of the IR subtype and the other subtypes were investigated. Based on pathological findings, HGSOCs were divided into two groups: those with or without abundant TILs. Results: Abundant TILs were detected in 17 cases of HGSOC (22.9%). Clinicopathological characteristics including age, CA125, FIGO stage, and residual disease did not show significant differences between the two groups. Lymph node metastasis was more common in the IR subtype group (p = 0.04). In the suboptimal surgery group, the 5-year PFS and OS (Kaplan–Meier estimates) in cases with (n = 10) or without (n = 21) abundant TILs were 10% and 0% (p = 0.097) and 70% and 28.5% (p = 0.012), respectively. The median time (range) to OS in cases with or without abundant TILs were 58 (34–81) months and 39 (22–55) months, respectively. Multivariate analysis in OS showed significant differences in TILs. Conclusions: Abundant intra-tumoral lymphocytic infiltration is an independent and favorable prognostic indicator for the suboptimal surgery group in HGSOCs and is associated with treatment response via cancer immunity.

6 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MSMami Shibahara
Mami Shibahara
HHHiroshi Harada
Hiroshi Harada
T栗Tomoko 栗田
Tomoko 栗田
MMMidori Murakami
Midori Murakami
YHYoshikazu Harada
Yoshikazu Harada
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background/Objectives: Tumour-infiltrating lymphocytes (TILs) significantly influence the prognosis of epithelial ovarian cancer (EOC). Advanced EOCs often cause neutrophilia, ascites, and malnutrition. The neutrophil-to-lymphocyte ratio (NLR) serves as a marker of systemic inflammation. This study investigated the prognostic significance of pre-treatment NLR and TILs in advanced EOCs. Methods: Overall, 101 advanced EOCs (stages III–IV, FIGO 2014) were treated between 2005 and 2020. Based on pathological findings, advanced EOCs were classified as having high or low TILs using CD8 and CD4 immunostaining. The tumour proportion score was calculated to determine PD-L1 expression. The number of marker-positive cells was counted using HALO. Progression-free survival and overall survival (OS) were compared between the high- and low-NLR groups based on TILs levels. Results: Clinicopathological characteristics, including age, FIGO stage, histological subtype, and postoperative residual disease, did not significantly differ among the four groups defined by NLR and intra-epithelial CD8+ TILs (CD8+ iTILs). Multivariate analysis of OS revealed that NLR and CD8+ iTILs were independent prognostic factors, and no correlation was observed between them. The 5-year OS rates were 82.2% in the low NLR–high CD8+ iTILs group (n = 25), 41.7% in the low NLR–low CD8+ iTILs group (n = 16), 47.2% in the high NLR–high CD8+ iTILs group (n = 34), and 26.0% in the high NLR–low CD8+ iTILs group (n = 26). In the low-NLR subgroup, OS was significantly prolonged in the high CD8+ iTILs group (p = 0.023). Conclusions: In advanced EOCs, the status of tumour-localised immunity and pre-treatment systemic inflammation influenced long-term prognosis.

4 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMami Shibahara
Mami Shibahara
HHHiroshi Harada
Hiroshi Harada
T栗Tomoko 栗田
Tomoko 栗田
MMMidori Murakami
Midori Murakami
YHYoshikazu Harada
Yoshikazu Harada
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background/Objectives: Tumour-infiltrating lymphocytes (TILs) significantly influence the prognosis of epithelial ovarian cancer (EOC). Advanced EOCs often cause neutrophilia, ascites, and malnutrition. The neutrophil-to-lymphocyte ratio (NLR) serves as a marker of systemic inflammation. This study investigated the prognostic significance of pre-treatment NLR and TILs in advanced EOCs. Methods: Overall, 101 advanced EOCs (stages III–IV, FIGO 2014) were treated between 2005 and 2020. Based on pathological findings, advanced EOCs were classified as having high or low TIL density using CD8 immunostaining. The number of marker-positive cells was counted using HALO. Progression-free survival and overall survival (OS) were compared between the high- and low-NLR groups based on CD8+ TIL levels. Results: Clinicopathological characteristics, including age, FIGO stage, histological subtype, and postoperative residual disease, did not significantly differ among the four groups defined by NLR and intra-epithelial CD8+ TILs (CD8+ iTILs). Multivariate Cox regression analysis of OS revealed that NLR and CD8+ iTILs were independent prognostic factors. The 5-year OS rates (Kaplan–Meier estimates) were 82.2% (median survival time not reached; range, 8–163 months) in the low NLR–high CD8+ iTIL group (n=25); 41.7% (46 months ; range, 2–109 months) in the low NLR–low CD8+ iTIL group (n=16); 47.2% (52 months; range, 1–181 months) in the high NLR–high CD8+ iTIL group (n=34); and 26.0% (24 months, 2–106 months) in the high NLR–low CD8+ iTIL group (n=26) (p<0.001). Conclusions: In advanced EOCs, the status of tumour-localised immunity and pre-treatment systemic inflammation influenced long-term prognosis.

27 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
THToru Hachisuga
Toru Hachisuga
YHYoshikazu Harada
Yoshikazu Harada
MSMami Shibahara
Mami Shibahara
MMMidori Murakami
Midori Murakami
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background: Immunoreactive (IR) subtype is one of the subtypes of high-grade serous ovarian carcinoma (HGSOC) with intra-tumoral lymphocytic infiltration. A positive prognostic correlation between IR subtype and R0 + optimal surgery has been reported. This study investigates the prognostic significance of the tumor-infiltrating lymphocytes (TILs) in the suboptimal surgery group of HGSOCs. Methods: After reviewing 318 malignant ovarian tumors detected in our database between 2000 and 2017, 74 HGSOCs with supplemental p53 immunostaining were selected. Differences in progression-free survival (PFS) and overall survival (OS) between the 2 groups of the IR subtype and the other subtypes were investigated. Based on pathological findings, HGSOCs were divided into 2 groups: those with or without abundant TILs. Results: Abundant TILs were detected in 17 cases of HGSOC (22.9%). Clinicopathological characteristics including age, CA125, FIGO stage, and residual disease did not show significant differences between the 2 groups. Lymph node metastasis was more common in the IR subtype group (p=0.04). In the suboptimal surgery group, the 5-year PFS and OS (Kaplan-Meier estimates) in cases with (n=10) or without (n=21) abundant TILs were 10% and 0% (P=0.097) and 70% and 28.5% (P=0.012), respectively. The median time (range) to OS in cases with or without abundant TILs were 58 (34-81) months and 39 (22-55) months, respectively. Multivariate analysis in OS showed significant differences in TILs. Conclusions: Abundant intra-tumoral lymphocytic infiltration is an independent and favorable prognostic indicator for the suboptimal surgery group in HGSOCs, and is associated with treatment response via cancer immunity.

1 June 2019 in Journal of UOEH
Verified
Journal Article
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
再生医学研究の源流の一つであるiPS細胞(induced pluripotent stem cell)の知見により,ほぼ全ての遺伝子情報が分化した体細胞にも精緻に保存され初期化・再分化できる可能性が明らかとなり,近年細胞内情報を書き換えることで性質を変化させようとする試みが多数みられる.今回我々はヒト発生期の生体内環境を参考に,腫瘍細胞の性質変化を起こす条件を追求し,受精前後の卵胞・卵管内における低酸素環境と無血清環境を模倣した培養実験系を構築した.さらには,発生期の免疫応答や多能性獲得にも関与するWnt/β-カテニンシグナル経路の阻害を併用することで,ヒト子宮平滑筋腫の培養細胞に脂肪分化誘導を惹起した.ヒト発生期の細胞内情報の動態を紹介しつつ,同実験系の可能性を述べる.